Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and young adults.

Drug regulators in Europe have found no evidence that popular diabetes and weight-loss drugs like Ozempic and Wegovy are linked to a higher risk of suicidal thoughts or actions.

Certain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart disease.

The popular weight-loss drug Wegovy can now be used to reduce the risk of stroke, heart attacks and other serious heart problems in patients who are overweight or who have obesity.

A new federal study finds that people taking popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions.

Obesity rates in the U.S. have been rising steadily for well over a decade and some of the world’s biggest drug developers are tapping into the growing treatment market.

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients.

A doctor talks about the effects of the wildly popular new drugs and what you should know before and after starting one.

Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.

The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.

Some compounding pharmacies are using a different form of an active ingredient, semaglutide, that is not approved by the FDA, state regulators say.

A diabetes drug being tested for weight loss is poised to further upend obesity care.

New guidelines suggest children struggling with obesity should be evaluated and treated early and aggressively.

Regulators say a new version of a popular diabetes medicine can be sold as a weight-loss drug in the U.S. The Food and Drug Administration on Friday approved Wegovy.